Effectiveness of levamisole HCl and thymalfasin in two mouse models of ALS
Levamisole HCl and Zadaxin tested in two mouse models of ALS
NDR White Papers
NDR
- Mar 31
- 4 min
White Paper Issue 16: Seeing ALS
Could optical coherence tomography be useful in stratifying ALS patients? Ocular nerves are specialized connections to the central...
5
NDR
- Mar 27
- 4 min
White Paper 15: Are in vitro Neuronal Cells Models for ALS discovery?
in vitro neuronal cells considered for ALS drug discovery
5
NDR
- Mar 2
- 6 min
White Paper Issue 14: Utility to Futility: Zilucoplan fails in human ALS trial
Thomas Edison famously said, “I haven’t failed—I’ve just found 10,000 that won’t work.” Unfortunately, that is the state of the art for...
73
NDR
- Feb 17
- 3 min
White Paper Issue 13: NDR’s Roadmap to an ALS Cure
Finding a cure for ALS is a lofty goal shared by all those involved in the field. The differences between the organizations that support...
10
NDR
- Jan 10
- 3 min
NDR White Paper Issue 11: Mechanisms of common pathologies in ALS
Despite the initial cause, all cases of ALS, familial or sporadic, follow a final common pathogenesis. The ability for the body to...
19
NDR
- Jan 7
- 4 min
NDR White Paper Issue 10: Genetics and ALS
In Ancient Egypt a person’s essence or soul was passed to their descendants, symbolized by Ka. Amyotrophic lateral sclerosis (ALS) has...
6
NDR
- Jan 5, 2021
- 1 min
White Paper 9: Stress Response in ALS: Dr. Robert Naviaux
Research in our lab has led to a new understanding of the ancient biology that underlies the circle of injury and recovery. New medicines...
11
NDR
- Dec 26, 2020
- 4 min
NDR White Paper Issue 8: ALS and epigenetics
Nothing illustrates that change is the essence of life quite like the butterfly. How does this cloudless sulphur caterpillar, eating the...
13
NDR
- Nov 20, 2020
- 7 min
NDR White Paper Issue 7: Models of ALS
Cathleen Lutz (Jackson Laboratory) described ALS as a “complex disease and consists of a group of conditions unified by a common theme,...
13
NDR
- Nov 5, 2020
- 4 min
NDR White Paper Issue 6: Energy Metabolism
NDR is approaching ALS from multiple directions- currently we have 17 active projects! What is fascinating is the emerging overlap...
9
NDR
- Aug 28, 2020
- 3 min
NDR White Paper Issue 5: Activity of Thymosan
Immunonormalizing molecules thymopoietin and levamisole HCl Inflammation and regulation of inflammatory responses are necessary for life....
22
NDR
- Aug 4, 2020
- 4 min
NDR White Paper Issue 4: C9orf72
RAN Proteins The discovery of a repeat expansion1 in the C9orf72 gene is important because it is a model to explain central...
7
NDR
- May 15, 2020
- 3 min
NDR White Paper Issue 3: Adipose & Secretome
The role of fat cells in treatment of ALS Amyotrophic lateral sclerosis is a (heterogeneous) neurodegenerative disorder with a variable...
9
NDR
- May 7, 2020
- 5 min
NDR White Paper Issue 2: Treatments Are Lacking
NDR’s goals are simple, bring promising therapies to ALS patients and know which treatment is appropriate for a patient by evaluating...
8
NDR
- May 1, 2020
- 3 min
NDR White Paper Issue 1: Thymopoietin
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease of animals and man with life-altering consequences. The defining pathology...
28